1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine, 95.0%, 250mg

4-Fluoro-2-methoxybenzoic acid, 98.0%, 1g

Methyl 5-Fluoronicotinate, 97.0%, 5g

4-Fluoro-N-piperidin-3-yl-benzenesulfonamide hydrochloride, 95.0%, 100mg

3-(tert-Butyl)-1H-pyrazole-4-carbaldehyde, 95.0%, 5g

tert-Butyl 5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 1g

2,4,5,6-Tetrakis(diphenylamino)isophthalonitrile, 95%, 250mg

Triphenylsulfonium Hexafluorophosphate>98.0%(HPLC)25g

Methyl 2-(piperidin-4-yl)thiazole-4-carboxylate, 98%, 500mg

tert-Butyl 4-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 1g

1-Ethyl-4-methylpyridin-1-ium Bromide, 98% HPLC,T, 100g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

Single-channel microliter pipette Pipetman® L, 10 to 100 µl, P100L, 1 piece